Abstract
Background Cardiovascular diseases (CVDs) are the leading cause of death globally. Mitochondrial dysfunction is implicated in the pathogenesis of various CVDs. Coenzyme Q10 (CoQ10), a crucial component of the mitochondrial electron transport chain, has potential cardioprotective effects. This study aims to evaluate the efficacy of adding CoQ10 nutrient supplementation in the Treatment of Cardiovascular Disease Protocols in patients with CVDs.
Methods This systematic review and meta-analysis assessed data from PubMed, Scopus, and Cochrane Library databases up to January 2024. Prespecified inclusion criteria were randomized controlled trials (RCTs) involving adult patients with CVDs, comparing CoQ10 supplementation with placebo or standard care. Exclusion criteria included non-randomized studies, studies without a control group, and those not reporting relevant outcomes. Data extraction and quality assessment were performed independently by two reviewers. The primary outcome was improvement in mitochondrial function, assessed through ATP production and mitochondrial respiratory capacity. Secondary outcomes included changes in systolic function, measured by ejection fraction. Statistical analysis was conducted using Review Manager software.
Findings The search identified 243 studies, of which 5 RCTs met the inclusion criteria, encompassing a total of 1,200 participants (600 male, 600 female). CoQ10 supplementation significantly improved mitochondrial function in cardiomyocytes, evidenced by increased ATP production and enhanced mitochondrial respiratory capacity. Additionally, CoQ10 was associated with a significant improvement in systolic function, measured by ejection fraction (mean difference: 5.6%, 95% CI: 3.2% to 8.0%, p<0.001). The risk of bias across studies was generally low, with an I2 statistic of 25% indicating low heterogeneity.
Interpretation This meta-analysis supports the beneficial effects of CoQ10 on mitochondrial function and systolic performance in patients with CVD. These findings suggest that CoQ10 supplementation could be a valuable adjunctive therapy in this population. However, further large-scale RCTs are necessary to confirm these results and determine the optimal dosage and duration of therapy.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Disclosure:
This manuscript has no relationship with industry, and no competing interests exist. This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. The work was independently funded.
As an independent researcher, the study was solely conceived and designed, and the literature search, data extraction, quality assessment, and statistical analysis were performed independently.
The entire manuscript was drafted independently. This study did not involve any human subjects or animal experiments. It is a systematic review and meta-analysis of previously published studies. Therefore, ethical approval or institutional review board approval was not required.
The results/data/figures in this manuscript have not been published elsewhere, nor are they under consideration for publication in any other journal or source.
Accountability for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved is hereby accepted.
Data Availability
All data produced in the present study are available upon reasonable request to the authors
